We are live on ! Find out more
AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $218B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
-1.38%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$97.1B
AUM Growth
+$19.4B
Cap. Flow
+$24.4B
Cap. Flow %
25.14%
Top 10 Hldgs %
12.02%
Holding
3,234
New
374
Increased
1,828
Reduced
905
Closed
84

Top Buys

Rank Stock Value
1
ANET icon
Arista Networks
ANET
+$474M
2
SNOW icon
Snowflake
SNOW
+$418M
3
GM icon
General Motors
GM
+$395M
4
RBLX icon
Roblox
RBLX
+$378M
5
ADBE icon
Adobe
ADBE
+$377M

Top Sells

Rank Stock Value
1
SMAR
Smartsheet Inc.
SMAR
+$173M
2
PGR icon
Progressive
PGR
+$158M
3
HOOD icon
Robinhood
HOOD
+$155M
4
ABBV icon
AbbVie
ABBV
+$131M
5
LEN icon
Lennar Class A
LEN
+$115M

Sector Composition

Rank Sector Weight
1 Technology 22.11%
2 Financials 16.12%
3 Healthcare 13.87%
4 Consumer Discretionary 11.39%
5 Industrials 11.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALT icon
3151
Altimmune
ALT
$583M
-12,577
Closed -$90.7K
OSG
3152
Octave Specialty Group
OSG
$205M
-17,837
Closed -$226K
AMLX icon
3153
Amylyx Pharmaceuticals
AMLX
$2.63B
-188,386
Closed -$712K
APGE icon
3154
Apogee Therapeutics
APGE
$10.2B
-5,365
Closed -$243K
BBAR icon
3155
BBVA Argentina
BBAR
$3.36B
-12,252
Closed -$233K
BILL icon
3156
BILL Holdings
BILL
$4.93B
-47,222
Closed -$4M
BMA icon
3157
Banco Macro
BMA
$5.14B
-3,659
Closed -$356K
CAPR icon
3158
Capricor Therapeutics
CAPR
$228M
-11,097
Closed -$153K
CLBT icon
3159
Cellebrite
CLBT
$4B
-735,566
Closed -$16.2M
CLDX icon
3160
Celldex Therapeutics
CLDX
$3.48B
-21,724
Closed -$549K
CRNX icon
3161
Crinetics Pharmaceuticals
CRNX
$8.95B
-7,798
Closed -$399K
EXFY icon
3162
Expensify
EXFY
$211M
-21,950
Closed -$73.5K
FDL icon
3163
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.88B
-5,659
Closed -$228K
FL
3164
DELISTED
Foot Locker
FL
-20,946
Closed -$456K
FORR icon
3165
Forrester Research
FORR
$225M
-35,670
Closed -$559K
GEOS icon
3166
Geospace Technologies
GEOS
$69.2M
-11,497
Closed -$115K
GNE icon
3167
Genie Energy
GNE
$384M
-23,604
Closed -$368K
IDYA icon
3168
IDEAYA Biosciences
IDYA
$3.55B
-13,763
Closed -$354K
IEUR icon
3169
iShares Core MSCI Europe ETF
IEUR
$9.14B
-6,119
Closed -$330K
IMNM icon
3170
Immunome
IMNM
$2.97B
-10,276
Closed -$109K
KBWB icon
3171
Invesco KBW Bank ETF
KBWB
$6.77B
-3,163
Closed -$207K
KRNT icon
3172
Kornit Digital
KRNT
$815M
-477,179
Closed -$14.8M
KYMR icon
3173
Kymera Therapeutics
KYMR
$9.11B
-6,576
Closed -$265K
LVHI icon
3174
Franklin International Low Volatility High Dividend Index ETF
LVHI
$5.59B
-22,960
Closed -$701K
LZM icon
3175
Lifezone Metals
LZM
$372M
-12,338
Closed -$85.7K

Similar funds

AQR Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, AQR Capital Management held 3,234 positions worth $97.1B, up 25% from $77.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

AQR Capital Management deployed $24.4B of net new capital in Q1 2025, opening 374 new positions and adding to 1,828 existing holdings. Its largest new stake was Millrose Properties Inc: 1,839,302 shares worth $48.4M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Progressive, an estimated $158M trimmed.

  • AQR Capital Management's largest Q1 2025 buy was Millrose Properties Inc: 1,839,302 shares worth $48.4M.
  • AQR Capital Management added most to Arista Networks in Q1 2025, an estimated $474M increase.
  • AQR Capital Management's biggest Q1 2025 reduction was Progressive, cutting an estimated $158M.
  • AQR Capital Management fully exited Smartsheet Inc. in Q1 2025, selling an estimated $173M.
  • AQR Capital Management's ten largest holdings make up 12% of its $97.1B portfolio in Q1 2025.
  • AQR Capital Management opened 374 new positions and closed 84 in Q1 2025.
  • AQR Capital Management's portfolio value rose 25% quarter-over-quarter to $97.1B.

Based on AQR Capital Management's 13F filing for Q1 2025, filed 15 May 2025.